Alterations of the P53 gene and human papillomavirus (HPV) infection are associated with development of oral squamous cell carcinoma (OSCC). We aimed to identify mutation of P53 exon 8 codon 282 in OSCC and correlate these with HPV infection as well as histopathological grade of OSCC. Samples of known HPV infection status were studied including oral lesion cells, formalin-fixed paraffin embedded (FFPE) tissues from OSCC and exfoliated oral cells of matched age-sex controls. P53 exon 8 mutation was detected using the polymerase chain reaction (PCR). Mutation of codon 282 was identified by allele-specific oligonucleotide typing (ASO) using EvaGreen real-time PCR. The PCR products were analyzed by gel electrophoresis and melting curve analysis. Mutation of P53 exon 8 was seen in 81.7% and 69.6% of FFPE OSCC tissues and oral lesion cells, respectively. This was significantly higher than in controls (16.7%). Frequency of mutation did not differ between HPV-positive samples (62.5% and 81.8% in oral lesion cells and FFPE tissue samples, respectively) and HPV-negative samples (73.3% and 81.5% in oral lesion cells and FFPE tissue samples, respectively). This finding is similar to P53 codon 282 mutation that was found only in FFPE tissues (35.0%) and oral lesion cells (32.6%) from both HPV-positive and negative OSCC. Interestingly, frequency of mutation was higher in well-differentiated OSCC with HPV-infection (28.1%) than without HPV (14.8%). This result demonstrated a mutation hot spot in P53 associated with oral carcinogenesis and might be useful to guide chemotherapeutic modality for HPV-associated OSCC in northeast Thailand.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827–841. https://doi.org/10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P
Tsantoulis P, Kastrinakis N, Tourvas A, Laskaris G, Gorgoulis V (2007) Advances in the biology of oral cancer. Oral Oncol 43:523–534. https://doi.org/10.1016/j.oraloncology.2006.11.010
Krishna A, Singh S, Kumar V, Pal U (2015) Molecular concept in human oral cancer. Natl J Maxillofac Surg 6:9. https://doi.org/10.4103/0975-5950.168235
Kashiwazaki H, Tonoki H, Tada M, Chiba I, Shindoh M, Totsuka Y, Iggo R, Moriuchi T (1997) High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene 15:2667. https://doi.org/10.1038/sj.onc.1201438
Greenblatt M, Bennett WP, Hollstein M, Harris C (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855–4878
Fei P, El-Deiry WS (2003) P53 and radiation responses. Oncogene 22:5774. https://doi.org/10.1038/sj.onc.1206677
Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28:622–629. https://doi.org/10.1002/humu.20495
Xu J, Wang J, Hu Y, Qian J, Xu B, Chen H, Zou W, Fang JY (2014) Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity. Cell Death Dis 5:e1108. https://doi.org/10.1038/cddis.2014.75
Suzuki H, Komiya A, Aida S, Ito H, Yatani R, Shimazaki J (1996) Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Prostate 28:318–324. https://doi.org/10.1002/(SICI)1097-0045(199605)28:5<318::AID-PROS8>3.0.CO;2-7
He D, Zhang DK, Lam KY, Ma L, Ngan HYS, Liu SS, Tsao SW (1997) Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 72:959–964. https://doi.org/10.1002/(SICI)1097-0215(19970917)72:6<959::AID-IJC7>3.0.CO;2-O
Busby-Earle R, Steel C, Williams A, Cohen B, Bird C (1994) p53 mutations in cervical carcinogenesis–low frequency and lack of correlation with human papillomavirus status. Br J Cancer 69:732. https://doi.org/10.1038/bjc.1994.138
Oda D, Bigler L, Mao EJ, Disteche CM (1996) Chromosomal abnormalities in HPV-16-immortalized oral epithelial cells. Carcinogenesis 17:2003–2008. https://doi.org/10.1093/carcin/17.9.2003
Lo K, Mok C, Chung G, Huang D, Wong F, Chan M, Lee J, Tsao S (1992) Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection. Anticancer Res 12:1989–1994
Phusingha P, Ekalaksananan T, Vatanasapt P, Loyha K, Promthet S, Kongyingyoes B, Patarapadungkit N, Chuerduangphui J, Pientong C (2017) Human papillomavirus (HPV) infection in a case-control study of oral squamous cell carcinoma and its increasing trend in northeastern Thailand. J Med Virol 89:1096–1101. https://doi.org/10.1002/jmv.24744
Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC, Albertson DG (2005) Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24:4232. https://doi.org/10.1038/sj.onc.1208601
Trivedy C, Warnakulasuriya K, Tavassoli M, Steingrimsdottir H, Penhallow J, Maher R, Johnson N (1998) p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. J Oral Pathol Med 27:72–77. https://doi.org/10.1111/j.1600-0714.1998.tb02097.x
Nylander K, Schildt E, Eriksson M, Magnusson A, Mehle C, Roos G (1996) A non-random deletion in the p53 gene in oral squamous cell carcinoma. Br J Cancer 73:1381. https://doi.org/10.1038/bjc.1996.262
Ostwald C, Gogacz P, Hillmann T, Schweder J, Gundlach K, Kundt G, Barten M (2000) p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity. Int J Cancer 88:82–86. https://doi.org/10.1002/1097-0215(20001001)88:1<82::AID-IJC13>3.0.CO;2-N
Chuerduangphui J, Pientong C, Patarapadungkit N, Chotiyano A, Vatanasapt P, Kongyingyoes B, Promthet S, Swangphon P, Bumrungthai S, Pimson C (2017) Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma. Med Oncol 34:148. https://doi.org/10.1007/s12032-017-1010-6
Lee YS, Bae SM, Kwak SY, Park DC, Kim YW, Hur SY, Park EK, Han BD, Lee YJ, Kim CK (2006) Cell cycle regulatory protein expression profiles by adenovirus p53 infection in human papilloma virus-associated cervical cancer cells. Cancer Res Treat 38:168. https://doi.org/10.4143/crt.2006.38.3.168
Muller PA, Vousden KH (2014) Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 25:304–317. https://doi.org/10.1016/j.ccr.2014.01.021
Javid J, Masroor M, Rashid Mir A, Ahamad I, Farooq S (2012) Clinical and prognostic significance of R282W p53 gene mutation in North India patients with non small cell lung Cancer. Transl Med 2:2161–1025.1000110. https://doi.org/10.4172/2161-1025.1000110
Acharya S, Ekalaksananan T, Vatanasapt P, Loyha K, Phusingha P, Promthet S, Kongyingyoes B, Pientong C (2015) Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case–control study. J Oral Pathol Med 44:252–257
Kang CJ, Lin CY, Wang HM, Fan KH, Ng SH, Lee LY, Chen IH, Huang SF, Liao CT, Yen TC (2011) The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys 81:e223–e230. https://doi.org/10.1016/j.ijrobp.2011.03.060
Montoro JRMC, Hicz HA, Souza L, Livingstone D, Melo DH, Tiveron RC, Mamede RCM (2008) Prognostic factors in squamous cell carcinoma of the oral cavity. Rev Bras Otorrinolaringol 74:861–866. https://doi.org/10.1590/S0034-72992008000600008
Mishra A, Bharti AC, Varghese P, Saluja D, Das BC (2006) Differential expression and activation of NF-κB family proteins during oral carcinogenesis: role of high risk human papillomavirus infection. Int J Cancer 119:2840–2850. https://doi.org/10.1002/ijc.22262
Wong YK, Liu TY, Chang KW, Lin SC, Chao TW, Li PL, Chang CS (1998) p53 alterations in betel quid- and tobacco-associated oral squamous cell carcinomas from Taiwan. J Oral Pathol Med 27:243–248. https://doi.org/10.1111/j.1600-0714.1998.tb01950.x
Heaton CM, Durr ML, Tetsu O, Zante A, Wang SJ (2014) TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Laryngoscope 124. https://doi.org/10.1002/lary.24595
Thongsuksai P, Boonyaphiphat P, Sriplung H, Sudhikaran W (2003) p53 mutations in betel-associated oral cancer from Thailand. Cancer Lett 201:1–7. https://doi.org/10.1016/S0304-3835(03)00417-8
Zhang Y, Coillie S, Fang J, Xu J (2016) Gain of function of mutant p53: R282W on the peak? Oncogenesis 5:e196. https://doi.org/10.1038/oncsis.2016.8
Hsieh LL, Wang PF, Chen I-H, Liao CT, Wang HM, Chen MC, Chang JTC, Cheng AJ (2001) Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 22:1497–1503. https://doi.org/10.1093/carcin/22.9.1497
Sharan RN, Mehrotra R, Choudhury Y, Asotra K (2012) Association of betel nut with carcinogenesis: revisit with a clinical perspective. PLoS One 7:e42759
Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435
Scheidt JHG, Yurgel LS, Cherubini K, Figueiredo MAZ, Salum FG (2012) Characteristics of oral squamous cell carcinoma in users or non users of tobacco and alcohol. Revista Odonto Ciência 27:69–73
Paquette RL, Lee YY, Wilczynski SP, Karmakar A, Kizaki M, Miller CW, Koeffler HP (1993) Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer 72:1272–1280. https://doi.org/10.1002/1097-0142(19930815)72:4<1272::AID-CNCR2820720420>3.0.CO;2-Q
Dai M, Clifford GM, Le Calvez F, Castellsagué X, Snijders PJ, Pawlita M, Herrero R, Hainaut P, Franceschi S (2004) Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Res 64:468–471. https://doi.org/10.1158/0008-5472
Shima K, Kobayashi I, Saito I, Kiyoshima T, Matsuo K, Ozeki S, Ohishi M, Sakai H (2000) Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan. Br J Oral Maxillofac Surg 38:445–450. https://doi.org/10.1054/bjom.2000.0162
Singh RD, Patel KR, Patel PS (2016) p53 mutation spectrum and its role in prognosis of oral cancer patients: a study from Gujarat, West India. Mutat Res-Fund Mol M 783:15–26. https://doi.org/10.1016/j.mrfmmm.2015.12.001
Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM (2001) Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 125:1–9. https://doi.org/10.1067/mhn.2001.116979
Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, Fujinaga K, K-i N, Fukuda H (1996) Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 12:1663–1668
Attner P, Du J, Näsman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2011) Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer 128:2892–2897. https://doi.org/10.1002/ijc.25625
Klozar J, Kratochvil V, Salakova M, Smahelova J, Vesela E, Hamsikova E, Betka J, Tachezy R (2008) HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 265:75–82. https://doi.org/10.1002/ijc.25625
Brandwein M, Zeitlin J, Nuovo G, MacConnell P, Bodian C, Urken M, Biller H (1994) HPV detection using “hot start” polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 7:720–727
Sisk EA, Soltys SG, Zhu S, Fisher SG, Carey TE, Bradford CR (2002) Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 24:841–849. https://doi.org/10.1002/hed.10146
Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M (1998) Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Oncogene 16:2469. https://doi.org/10.1038/sj.onc.1201776
Lee LN, Shew JY, Sheu JC, Lee YC, Lee WC, Fang MT, Chang HF, Yu CJ, Yang PC, Luh KT (1994) Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med 150:1667–1671. https://doi.org/10.1164/ajrccm.150.6.7952630
Kozomara R, Brankovic-Magic M, Jovic N, Stosic S, Magic Z (2007) Prognostic significance of TP53 mutations in oral squamous cell carcinoma with human papilloma virus infection. Int J Biol Markers 22:252–257. https://doi.org/10.1177/172460080702200403
This work was supported by the Thailand Research Fund and Khon Kaen University through the Royal Golden Jubilee Ph.D. Program (grant number PHD/0296/2552, to W.W. and C.P.) and Invitation Research Grant, Faculty of Medicine, Khon Kaen University (grant number I56329). We would like to acknowledge Prof. David Blair, for editing the MS via Publication Clinic KKU, Thailand.
Ethics Approval and Consent to Participate
All procedures performed in studies involving human participants were approved by the Khon Kaen University Ethics Committee for Human Research (No. HE561407 and No. HE581211), in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Conflict of Interest
The authors have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ekalaksananan, T., Wongjampa, W., Phusingha, P. et al. Comprehensive Data of P53 R282 Gene Mutation with Human Papillomaviruses (HPV)-Associated Oral Squamous Cell Carcinoma (OSCC). Pathol. Oncol. Res. 26, 1191–1199 (2020). https://doi.org/10.1007/s12253-019-00673-6
- Human papillomavirus
- P53 mutation
- P53 exon 8 codon 282
- Oral squamous cell carcinoma
- Allele specific oligonucleotide